Cargando…
Drug screening for Pelizaeus-Merzbacher disease by quantifying the total levels and membrane localization of PLP1
BACKGROUND: Pelizaeus-Merzbacher disease (PMD) is caused by point mutations or copy number changes in the proteolipid protein 1 gene (PLP1). PLP1 is exclusively localized in the myelin sheath of oligodendrocytes. Amino acid-substituted PLP1 protein is unable to fold properly and is subsequently degr...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510973/ https://www.ncbi.nlm.nih.gov/pubmed/31110947 http://dx.doi.org/10.1016/j.ymgmr.2019.100474 |